| Year |
Citation |
Score |
| 2007 |
Grammatopoulos TN, Outeiro TF, Hyman BT, Standaert DG. Angiotensin II protects against alpha-synuclein toxicity and reduces protein aggregation in vitro. Biochemical and Biophysical Research Communications. 363: 846-51. PMID 17900533 DOI: 10.1016/J.Bbrc.2007.09.043 |
0.584 |
|
| 2007 |
Outeiro TF, Grammatopoulos TN, Altmann S, Amore A, Standaert DG, Hyman BT, Kazantsev AG. Pharmacological inhibition of PARP-1 reduces alpha-synuclein- and MPP+-induced cytotoxicity in Parkinson's disease in vitro models. Biochemical and Biophysical Research Communications. 357: 596-602. PMID 17449015 DOI: 10.1016/J.Bbrc.2007.03.163 |
0.516 |
|
| 2007 |
St Martin JL, Klucken J, Outeiro TF, Nguyen P, Keller-McGandy C, Cantuti-Castelvetri I, Grammatopoulos TN, Standaert DG, Hyman BT, McLean PJ. Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra. Journal of Neurochemistry. 100: 1449-57. PMID 17241127 DOI: 10.1111/J.1471-4159.2006.04310.X |
0.471 |
|
| 2007 |
Grammatopoulos TN, Jones SM, Ahmadi FA, Hoover BR, Snell LD, Skoch J, Jhaveri VV, Poczobutt AM, Weyhenmeyer JA, Zawada WM. Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra. Molecular Neurodegeneration. 2: 1. PMID 17224059 DOI: 10.1186/1750-1326-2-1 |
0.686 |
|
| 2005 |
Grammatopoulos TN, Ahmadi F, Jones SM, Fariss MW, Weyhenmeyer JA, Zawada WM. Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell death. Brain Research. 1045: 64-71. PMID 15910763 DOI: 10.1016/J.Brainres.2005.03.038 |
0.715 |
|
| 2004 |
Grammatopoulos TN, Johnson V, Moore SA, Andres R, Weyhenmeyer JA. Angiotensin type 2 receptor neuroprotection against chemical hypoxia is dependent on the delayed rectifier K+ channel, Na+/Ca2+ exchanger and Na+/K+ ATPase in primary cortical cultures. Neuroscience Research. 50: 299-306. PMID 15488293 DOI: 10.1016/J.Neures.2004.07.010 |
0.707 |
|
| 2004 |
Jing G, Grammatopoulos T, Ferguson P, Schelman W, Weyhenmeyer J. Inhibitory effects of angiotensin on NMDA-induced cytotoxicity in primary neuronal cultures. Brain Research Bulletin. 62: 397-403. PMID 15168905 DOI: 10.1016/J.Brainresbull.2003.10.011 |
0.699 |
|
| 2004 |
Moore SA, Huang N, Hinthong O, Andres RD, Grammatopoulos TN, Weyhenmeyer JA. Human angiotensin II type-2 receptor inhibition of insulin-mediated ERK-2 activity via a G-protein coupled signaling pathway. Brain Research. Molecular Brain Research. 124: 62-9. PMID 15093686 DOI: 10.1016/J.Molbrainres.2004.02.006 |
0.683 |
|
| 2004 |
Grammatopoulos TN, Morris K, Bachar C, Moore S, Andres R, Weyhenmeyer JA. Angiotensin II attenuates chemical hypoxia-induced caspase-3 activation in primary cortical neuronal cultures. Brain Research Bulletin. 62: 297-303. PMID 14709344 DOI: 10.1016/J.Brainresbull.2003.09.018 |
0.706 |
|
| 2003 |
Ahmadi FA, Linseman DA, Grammatopoulos TN, Jones SM, Bouchard RJ, Freed CR, Heidenreich KA, Zawada WM. The pesticide rotenone induces caspase-3-mediated apoptosis in ventral mesencephalic dopaminergic neurons. Journal of Neurochemistry. 87: 914-21. PMID 14622122 DOI: 10.1046/J.1471-4159.2003.02068.X |
0.327 |
|
| 2002 |
Moore SA, Patel AS, Huang N, Lavin BC, Grammatopoulos TN, Andres RD, Weyhenmeyer JA. Effects of mutations in the highly conserved DRY motif on binding affinity, expression, and G-protein recruitment of the human angiotensin II type-2 receptor. Brain Research. Molecular Brain Research. 109: 161-7. PMID 12531525 DOI: 10.1016/S0169-328X(02)00552-1 |
0.695 |
|
| 2002 |
Grammatopoulos T, Morris K, Ferguson P, Weyhenmeyer J. Angiotensin protects cortical neurons from hypoxic-induced apoptosis via the angiotensin type 2 receptor. Brain Research. Molecular Brain Research. 99: 114-24. PMID 11978402 DOI: 10.1016/S0169-328X(02)00101-8 |
0.743 |
|
| Show low-probability matches. |